MedImprove
ActiveSummary
MedImprove has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €301,052 and a net result of €176,363. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 29% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Register details
Identification
Legal formPrivate limited company
Founded30-11-2020
Financial year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
86220Specialist medical practice
72109Other research and development on natural sciences
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0758914241
Also
9925:BE0758914241
Registered
31-10-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Mortsel · 1 establishment unit since 2020
Ground area
494 m²
Building footprint
366 m²
Building volume
2,468 m³
Parcel 11029A0146/00D008, Flanders · tallest building 14.2 m. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
MedImprove
since 2020unit no. 2.310.747.559
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11029A0146/00D008 | Flanders | 493 m² | 1 · 366 m² | 14.2 m · 1 |
How the parcels are linked
Good to know
The parcel matches the address exactly.